All practices and processes applied by the Group hospitals demonstrate our transparent commitment to continue improving the quality and safety of the care provided to our patients.
From the very first moment the first coronavirus case was identified in Greece, our hospitals responded immediately, implementing all the necessary measures to safeguard their facilities, protecting the health of their patients and employees.
Assisted by the competent Infection Control Committee (ICC), at MITERA we apply all the approved operational rules and safety protocols, strictly taking into account the guidelines issued by the National Public Health Organization (NPHO), the Greek Ministry of Health and international organizations.
Guided by distinguished infectious disease specialists, the ICC ensures continuous updates regarding the developments with COVID-19, actively contributes in overseeing and organizing safety protocols, and remains on alert when it comes to monitoring the seamless and safe operation of the Hospital. It mainly focuses on ensuring that all the hospital departments work closely together and the staff receive continuous updates and training.
The following protective measures are in place at HYGEIA Group:
Entry to MITERA Hospital is only possible from checkpoints, where full compliance with the use of the mask is ensured, while careful assessment of all individuals arriving is carried out for possible symptoms consistent with COVID-19.
If someone exhibits symptoms of the disease, they are directed to a specially designed negative pressure room via a secure route, where they receive all the necessary medical care under high-protection conditions.
The following precautionary measures have been taken to avoid overcrowding in waiting areas:
- The doctors and nurses wear surgical masks during the time the Clinic is open.
- Patient appointments are scheduled depending on the required time for the examination, so as to avoid crowding of patients in the waiting areas.
- All patients arrive wearing a protective mask, which they keep on for as long as they remain at the Hospital.
- All patients fill out a special COVID-19 infection questionnaire. If a patient experiences symptoms consistent with the disease, the on-call internist is called to assess the case and decide on whether a specimen should be collected for molecular testing. If a specimen is sent for COVID-19 testing, the examination is postponed and the patient may return after the results have been issued.
- For invasive procedures performed at the Outpatient Clinic which require general anesthesia, the patient must submit a COVID-19 molecular test result by a certified lab, which must have been carried out 1-3 days before the scheduled procedure.
- Entry to individuals accompanying patients is forbidden, unless deemed absolutely necessary.
- The safe distance of 2 m between patients and the rule of 1 person per 10 sqm are observed in the waiting areas. If this is not possible due to limited space, patients are directed to another waiting area and are called when it is their turn.
- The doctor’s offices are adequately ventilated, preferably naturally. Where natural ventilation is not possible, the air is renewed through central air conditioning units, in accordance with the instructions in the Ministry of Health circular with ref. no. Δ1(δ)/ΓΠ οικ. 26635.
- Once the patients leave, all the areas and equipment used during the exam are disinfected.
- In medical emergencies, all the exams are performed before the COVID-19 result is received. In these cases, a COVID-19 specimen is collected, if it has not been collected already, and the patients are treated as if they are positive, while the medical, nursing and auxiliary staff use all the required personal protective equipment (waterproof surgical gown, mask, gloves, cap and face shield or goggles).
For the safety of patients and visitors as well as the medical, nursing and other staff, a COVID-19 test is performed in the following cases:
- All admissions, irrespective of reason
- Scheduled diagnostic tests on inpatients in cases of possible aerosol creation
- Emergency surgery on outpatients or emergency invasive diagnostic tests
- Patients hospitalized at MITERA for more than 6 days who will undergo a surgical or invasive procedure
- Oncology patients at the beginning of their first treatment
How is the test for the SARS-CoV-2 coronavirus performed?
The outbreak of the SARS-CoV-2 pandemic, placed the A-Lab, the HHG Molecular Biology and Genetics Center, at the front line of the fight against the coronavirus. Responding to the needs of all Group hospitals, the A-Lab immediately proceeded with providing molecular detection of the new virus strain, the only method that offers a fast and reliable result.
All specimens collected at the Group hospitals are treated as potentially infectious and, consequently, all the necessary protection and spread prevention measures are applied throughout the processes of collection, packaging, storage and transfer of specimens. The professionals participating in the entire specimen management process wear PPE.
Triple packaging is used when transferring the clinical specimens to the lab, located outside the hospital premises.
Real Time RT-PCR Method
Once the specimens are received by the lab, the viral RNA is isolated and polymerase chain reaction with reverse transcription is applied to amplify 2 different targets of the SARS-CoV-2 viral genome. The test is concluded within 3 to 4 hours from the time the specimens are received by the lab.
Find out more about SARS-CoV-2 coronavirus testing here
Individuals or patients visiting the hospital often, such as pregnant women and patients on dialysis, fill out a special COVID-19 questionnaire on every visit. If the patient reports a symptom that is consistent with COVID-19, they are assessed by the on-call internist and a COVID-19 specimen is collected if deemed necessary. If a specimen is sent for COVID-19 testing, the examination is postponed until the results have been issued.
Τhe Infection Control Committee ensures continuous updates regarding the developments with COVID-19, actively contributes in overseeing and organizing safety protocols, and remains on alert when it comes to monitoring the seamless and safe operation of the Hospital.
Measures for the children
MITERA Children’s Hospital Outpatient Clinic
Anyone visiting the MITERA Children’s Hospital Outpatient Clinic fills out the special COVID-19 questionnaire. In the case where a symptom that is consistent with COVID-19 is reported, the on-call pediatrician makes an assessment and a specimen is collected for molecular testing if deemed necessary.
If they experience no symptoms, they may enter the area after having had their temperature taken and provided they wear a mask.
Only one parent per patient is permitted during visits to the regular clinics.
MITERA Children’s Hospital inpatients
Both parents are permitted entry for children hospitalized at MITERA Children’s Hospital, but only one parent may stay with the child overnight.
Our key priority at HYGEIA Group is to provide quality services to safeguard the health of our patients.
Patient visits are restricted, with only 1 visitor or carer per patient, while the visit may not exceed 30 minutes. Entry to individuals who are not healthy is not permitted.
All patients and carers are required to wear masks and remain in the patient’s room throughout their visit.
There is strict adherence to the visiting hours, unless a special written permit has been received, signed by the treating physician (patients who are unable to care for themselves).
Neonatal Intensive Care Unit (NICU)
Visits to the NICU I are permitted once daily, from 11:30 to 12:00 or 19:30 to 20:00, and to the NICU II and III once daily, from 13:00 to 14:00 or 19:00 to 20:00. Only 2 people per department (NICU I, II, III) are permitted entry at a time, while the visit may not exceed 10 minutes. Only visual contact with the neonates is permitted. Breastfeeding mothers may feed their neonates whenever they wish so.